Lilly launches Tanstrive (Selpercatinib), a RET inhibitor to treat advanced cancers with RET gene… EP News Bureau Jun 25, 2026 Available in India in 40 mg, 80 mg, 120 mg and 160 mg tablet strengths; administered orally twice daily
